New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers identify a promising new drug target for rare liver cancer

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re
Oncology January 29,2024
Researchers identify a promising new drug target for rare liver cancer

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re
Oncology January 29,2024
COVID reforms in cancer care and research could have long-term benefits

COVID reforms in cancer care and research could have long-term benefits

by King's College LondonCredit: Unsplash/CC0 Public DomainA new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that s
Oncology January 29,2024
COVID reforms in cancer care and research could have long-term benefits

COVID reforms in cancer care and research could have long-term benefits

by King's College LondonCredit: Unsplash/CC0 Public DomainA new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that s
Oncology January 29,2024
Researchers identify the standard for gallbladder cancer surgery

Researchers identify the standard for gallbladder cancer surgery

by Boston University School of MedicineCredit:Annals of Surgical Oncology(2023). DOI: 10.1245/s10434-023-13531-2The quality of surgery can drastically influence both short- and long-t
Oncology January 29,2024
Researchers identify the standard for gallbladder cancer surgery

Researchers identify the standard for gallbladder cancer surgery

by Boston University School of MedicineCredit:Annals of Surgical Oncology(2023). DOI: 10.1245/s10434-023-13531-2The quality of surgery can drastically influence both short- and long-t
Oncology January 29,2024
Fatty liver is increasingly the cause of liver cell cancer

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00
Oncology January 29,2024
Fatty liver is increasingly the cause of liver cell cancer

Fatty liver is increasingly the cause of liver cell cancer

by Stefan Zorn, Medizinische Hochschule HannoverCredit: Pixabay/CC0 Public DomainHepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,00
Oncology January 29,2024
Treatment found to reduce progression of rare blood cancer by 74%

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type
Oncology January 29,2024
Treatment found to reduce progression of rare blood cancer by 74%

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type
Oncology January 29,2024
Study shows how liver cancer hijacks circadian clock machinery inside cells

Study shows how liver cancer hijacks circadian clock machinery inside cells

by Keck School of Medicine of USCPictured is an artist's rendering of circadian clock proteins BMAL1 and CLOCK influencing hepatocellular carcinoma (HCC) cell proliferation. The study shows t
Oncology January 29,2024
Study shows how liver cancer hijacks circadian clock machinery inside cells

Study shows how liver cancer hijacks circadian clock machinery inside cells

by Keck School of Medicine of USCPictured is an artist's rendering of circadian clock proteins BMAL1 and CLOCK influencing hepatocellular carcinoma (HCC) cell proliferation. The study shows t
Oncology January 29,2024
Study identifies biomarker that may predict treatment response to chemoimmunotherapy

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo
Oncology January 29,2024
Study identifies biomarker that may predict treatment response to chemoimmunotherapy

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo
Oncology January 29,2024
Researchers design multiclass cancer diagnostic tool using AI and miRNA

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique
Oncology January 28,2024
Researchers design multiclass cancer diagnostic tool using AI and miRNA

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique
Oncology January 28,2024
From cavefish to humans: Evolution of metabolism in cavefish may provide insight into treatments for a host of diseases

From cavefish to humans: Evolution of metabolism in cavefish may provide insight into treatments for a host of diseases

by Stowers Institute for Medical ResearchMorphological differences between cavefish (top) compared with surface-dwelling river fish (bottom). Credit: Stowers Institute for Medical ResearchNew res
Diabetes & Endocrinology January 28,2024
From cavefish to humans: Evolution of metabolism in cavefish may provide insight into treatments for a host of diseases

From cavefish to humans: Evolution of metabolism in cavefish may provide insight into treatments for a host of diseases

by Stowers Institute for Medical ResearchMorphological differences between cavefish (top) compared with surface-dwelling river fish (bottom). Credit: Stowers Institute for Medical ResearchNew res
Diabetes & Endocrinology January 28,2024
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c
Oncology January 28,2024
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c
Oncology January 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com